Stable Isotope Labelled Vudalimab Biosimilar – Anti-CTLA4;PDCD1 mAb – Research Grade

Reference: PX-TA1739-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Vudalimab Biosimilar - Anti-CTLA4;PDCD1 mAb - Research Grade
SourceCAS 2329669-72-7
SpeciesHumanized
Expression systemXtenCHO
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsANTI-PD-1/ANTI-CTLA-4 XMAB20717, IMMUNOGLOBULIN HALF-IG G1-KAPPA/SCFV-H-CH2-CH3, ANTI-(HOMO SAPIENS CTLA4 (CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4, CD152)) AND ANTI-(HOMO SAPIENSPDCD1 (PROGRAMMED CELL DEATH 1, PD-1, PD1, CD279)), MONOCLONAL ANTIBODY, BISPECIFIC
ReferencePX-TA1739-SIL
Related ProductsPX-P4361
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeBispecific ,IgG1,Kappa;Kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Vudalimab Biosimilar – Anti-CTLA4;PDCD1 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products